Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated
- DrugBank Accession Number
- DB15484
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to prevent Cholera caused by vibrio cholerae serogroup o1 Combination Product in combination with: Vibrio cholerae Ogawa 50 classical biotype, heat inactivated (DB15486), Vibrio cholerae Inaba 48 classical biotype, heat inactivated (DB15485), Recombinant Cholera Toxin B Subunit (DB11643), Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated (DB15487) •••••••••••• •••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Dukoral Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated (31250000000 cells / dose) + Recombinant Cholera Toxin B Subunit (1 mg / dose) + Vibrio cholerae Inaba 48 classical biotype, heat inactivated (31250000000 cells / dose) + Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated (31250000000 cells / dose) + Vibrio cholerae Ogawa 50 classical biotype, heat inactivated (31250000000 cells / dose) Suspension Oral Valneva Sweden Ab 2003-04-15 Not applicable Canada Dukoral Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated (31250000000 bacteria) + Recombinant Cholera Toxin B Subunit (1 mg) + Vibrio cholerae Inaba 48 classical biotype, heat inactivated (31250000000 bacteria) + Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated (31250000000 bacteria) + Vibrio cholerae Ogawa 50 classical biotype, heat inactivated (31250000000 bacteria) Suspension Oral Valneva Sweden Ab 2022-06-08 Not applicable EU DUKORAL Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated (25000000000 unit) + Recombinant Cholera Toxin B Subunit (1 mg) + Vibrio cholerae Inaba 48 classical biotype, heat inactivated (25000000000 unit) + Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated (25000000000 unit) + Vibrio cholerae Ogawa 50 classical biotype, heat inactivated (25000000000 unit) Suspension Oral Valneva Sweden Ab 2014-07-08 Not applicable Italy Dukoral Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated (31250000000 bacteria) + Recombinant Cholera Toxin B Subunit (1 mg) + Vibrio cholerae Inaba 48 classical biotype, heat inactivated (31250000000 bacteria) + Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated (31250000000 bacteria) + Vibrio cholerae Ogawa 50 classical biotype, heat inactivated (31250000000 bacteria) Suspension Oral Valneva Sweden Ab 2022-06-08 Not applicable EU DUKORAL Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated (25000000000 unit) + Recombinant Cholera Toxin B Subunit (1 mg) + Vibrio cholerae Inaba 48 classical biotype, heat inactivated (25000000000 unit) + Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated (25000000000 unit) + Vibrio cholerae Ogawa 50 classical biotype, heat inactivated (25000000000 unit) Suspension Oral Valneva Sweden Ab 2014-07-08 Not applicable Italy
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Immunity / Kidney Transplantation 1 4 Recruiting Prevention Cholera (Disorder) / Disease caused by Salmonella typhi / Vaccine Preventable Diseases 1 2 Terminated Treatment Ulcerative Colitis 1 1 Completed Basic Science Infection 1 1 Completed Prevention Inflammatory Bowel Diseases (IBD) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Suspension Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at August 30, 2019 18:06 / Updated at December 11, 2021 01:26